The Fondation pour Recherches Médicales is delighted to welcome MesenFlow Technologies to La Tulipe. Their arrival further strengthens a community bringing together researchers, entrepreneurs and startups around biomedical research and healthcare innovation.
MesenFlow develops human tissue-based preclinical platforms designed to recreate and study inflammation under physiological flow conditions. Combining bio-imaging with AI-powered analysis, its technologies make it possible to track immune cell behaviour in real time and study their interactions with vascular and tissue environments.
These models aim to generate more human-relevant data from the early stages of preclinical development while helping to reduce reliance on animal testing. MesenFlow’s solutions have applications across several fields, including inflammation, oncology and toxicology.
MesenFlow’s new location at La Tulipe, in close proximity to Geneva University Hospitals (HUG) and the University of Geneva Faculty of Medicine, also provides an environment that fosters connections between research, innovation and clinical practice.
We are very pleased to welcome them to our growing community and look forward to the exchanges, synergies and new collaborations that this proximity may create.
🌷 Welcome to La Tulipe, MesenFlow Technologies!
A dedicated MesenFlow page will soon be available on our website, providing more information about their team, technologies and activities.
Learn more:
MesenFlow Technologies website: https://www.mesenflow.com/
Read MesenFlow’s announcement about their move to La Tulipe: https://lnkd.in/p/enc9Z5bs
